Danaher Corp. Stock
€246.00
Your prediction
Danaher Corp. Stock
Pros and Cons of Danaher Corp. in the next few years
Pros
Cons
Performance of Danaher Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Danaher Corp. | -0.060% | -1.049% | 2.486% | 19.078% | 16.921% | -5.943% | 94.436% |
| Parker-Hannifin | 1.700% | -0.774% | 8.330% | 55.311% | 34.605% | 124.324% | 261.008% |
| Stanley Black & Decker Inc. | 0.720% | 0.062% | 7.137% | 28.963% | 8.212% | -35.690% | -22.428% |
| IDEX Corp. | 0.730% | -0.209% | 3.701% | -3.421% | -2.904% | 4.698% | 30.514% |
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Danaher Corporation, with the US trading symbol DHR, is a major player in the Machinery, Equipment & Components industry. After evaluating its financial statements, one can generally conclude that the company has shown remarkable growth and strength over the past few years. With a solid balance sheet and consistent cash flow generation, Danaher appears to be positioned well for future growth. However, as with any company, there are certain aspects that warrant close attention.
Pros
Earnings growth: Net income has shown an upward trend, growing from $3.65 billion in 2020 to $7.21 billion in 2022. This is indicative of the company's financial strength and profitability.
Comments
News
Here's Why Shares in This Hot Healthcare Stock Surged This Week
The bioprocessing market is about to recover. That's the conclusion from Repligen's (NASDAQ: RGEN) second-quarter earnings report released earlier in the week and the reason for the stock's 17.7%
Here's Why Danaher Stock Surged Today
Danaher's (NYSE: DHR) core revenue decline of 3.5% in the second quarter might not seem like anything to write home about. Still, as ever in investing, it's about context, and the company's earnings